首页> 外文期刊>The Journal of craniofacial surgery >Clinical parameters in T1N0M0 lower lip squamous cell carcinoma.
【24h】

Clinical parameters in T1N0M0 lower lip squamous cell carcinoma.

机译:T1N0M0下唇鳞状细胞癌的临床参数。

获取原文
获取原文并翻译 | 示例
           

摘要

This retrospective study was carried out to asses the clinical outcome of T1 (i.e., tumor 2 cm or less at greatest dimension) squamous cell carcinoma of the lower lip (SCCLL) and verify the impact of some clinical parameters on prognosis. Fifty-seven patients with histologically proven T1 SCCLL were analyzed. Fifty-two patients were never treated before admission, whereas five (8.8%) had a second radical resection of the primary tumor location; none had neck nodes (i.e., N0) or distant metastasis (i.e., M0).The global disease-specific survival rate at 32 months was 100%, irrespective of grading and type of surgery, and thus no differences were statistically detected. Therefore, we concluded that radical tumor resection is a viable procedure for T1 SCCLL, irrespectively of grading. In addition, a second surgery on the primary tumor location is possible and has effectiveness on survival. Finally, neck dissection is not necessary in cases of T1 SCCLL.
机译:进行这项回顾性研究以评估T1下唇鳞状细胞癌(SCCLL)的临床结局(即最大尺寸小于等于2厘米的肿瘤),并验证某些临床参数对预后的影响。对57例经组织学证实为T1 SCCLL的患者进行了分析。 52例患者入院前从未接受过治疗,而5例(8.8%)对原发肿瘤部位进行了第二次根治性切除术。没有人有颈部淋巴结转移(即N0)或远处转移(即M0).32个月的总体疾病特异性生存率为100%,与手术等级和手术类型无关,因此没有统计学差异。因此,我们得出结论,无论分级如何,根治性肿瘤切除术都是可行的T1 SCCLL手术方法。另外,可以对原发肿瘤部位进行第二次手术,并且对生存有效。最后,在T1 SCCLL的情况下无需进行颈部解剖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号